We are positioned to advance numerous therapeutic categories, including pharmaceutical cannabis.

Corporate Profile

CURE Pharmaceutical® is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug forms and delivery systems.

CURE has an FDA-registered, cGMP manufacturing facility and is a pioneering developer of CUREform™, a patented drug delivery platform which includes CUREfilm®, one of the most advanced oral thin films on the market today; CUREpods™ a novel chewable delivery system and other more traditional dose forms that use advanced encapsulation technology. CUREform’s combined technologies provide opportunities for both immediate and controlled-release drug delivery of a wide range of active ingredients.

CURE partners with biotech, pharmaceutical, and wellness companies worldwide and has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector, with partnerships in the U.S.A, Canada, Israel, and other markets.

Cure Pharmaceutical Corporation was founded in July 2011 and is a wholly-owned subsidiary of Cure Pharmaceutical Holding Corp, a public company.

Stock Today



CURE Pharmaceutical
1620 Beacon Place
Oxnard, CA 93033
Phone: (805) 824-0410
Fax: (805) 487-7163

Our Investor Presentation

  • CUSIP Number: 23127P104
  • Number of Fulltime Employees: 15
  • Fiscal Year Ends: 12/31

Management Team

Board of Directors

Key Contacts

Investor Relations

Liviakis Financial
655 Redwood Hwy. #395
Mill Valley, CA 94942

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598


805 3rd Avenue #1430
New York, NY 10022

Corporate Counsel

K&L Gates
10100 Santa Monica Blvd., 8th Fl.
Los Angeles, CA 90067